Robert P. Collins

This profile gathers the share dealings of Robert P. Collins across 2 companies, led by Zep Inc. and Serologicals Corp. The record holds 61 filings, for trades running from 15 March 2006 to 26 June 2015.

Market trades split into 1 purchase (€158k) and 4 sales (€776k). Taken together, the sales exceed the purchases by €619k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 38 share grants and 13 option exercises. 2015 to date brings no purchases and 4 sales.

The newest entry dates from 30 June 2015: a transaction, in Zep Inc. The last purchase on record was published on 28 October 2009, which is 6,205 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.